Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
Norbert Hauel(Boehringer Ingelheim (Germany)), Wolfgang Wienen(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Henning Priepke(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Uwe J. Ries(Boehringer Ingelheim (Germany)), Jean–Marie Stassen(Boehringer Ingelheim (Germany))
Cited by 454
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374